THE PETRIZZO GROUP, INC.

Lobbying for OMEROS CORPORATION · Pharmaceuticals

Filing Registration - Amendment

3rd Quarter (July 1 - Sep 30) 2026 · Washington · posted Jul 21, 2026

Lobbying activity 2

Health Issues

Issues involving the rare pediatric disease priority review voucher.

Medical/Disease Research/Clinical Labs

Issues involving the rare pediatric disease priority review voucher.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.